Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral metronidazole for pain after open haemorrhoidectomy
ACTRN12619000492156Phase 4Not yet recruiting
- Sponsor
- Dr Grahame Ctercteko
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hemorrhoid comparing Metronidazole with Placebo (2 arms). Primary endpoint: Post-operative pain days 1-7. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
metronidazole
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on ACTRN12619000492156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000492156.